TrialCancer2013

Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.

Daruka Mahadevan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.